Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3

Watchlist Manager
Oncoclinicas do Brasil Servicos Medicos SA Logo
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
Watchlist
Price: 9.15 BRL -0.54% Market Closed
Updated: May 31, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

62.1m
Operating Cash Flow
Growth Rates:
1 Year
-
3 Years
-46%
5 Years
-
7 Years
-
10 Years
-
-282.1m
Investing Cash Flow
Growth Rates:
1 Year
+2%
3 Years
-19%
5 Years
-
7 Years
-
10 Years
-
223m
+100%
Financing Cash Flow
Growth Rates:
1 Year
-55%
3 Years
-55%
5 Years
-
7 Years
-
10 Years
-

Cash Flow Statement
Oncoclinicas do Brasil Servicos Medicos SA

Rotate your device to view
Cash Flow Statement
Currency: BRL
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Operating Cash Flow
Net Income
(125)
(98)
(297)
(169)
(22)
(45)
133
40
114
171
230
322
313
291
Depreciation & Amortization
107
111
124
125
127
134
145
168
175
200
216
235
257
265
Change in Deffered Taxes
0
(12)
(8)
(10)
0
9
65
(53)
0
0
0
0
0
0
Other Non-Cash Items
168
158
358
242
132
97
(103)
40
(1)
23
39
(52)
31
44
Cash Taxes Paid
42
37
54
56
95
107
144
117
189
251
97
75
47
62
Cash Interest Paid
39
58
64
80
129
121
187
236
349
404
458
481
491
474
Change in Working Capital
(52)
(44)
(256)
(249)
(245)
(380)
(565)
(572)
(560)
(736)
(345)
(280)
(652)
(538)
Cash from Operating Activities
98
N/A
116
+19%
(79)
N/A
(61)
+23%
(9)
+85%
(185)
-1 891%
(324)
-75%
(378)
-17%
(272)
+28%
(346)
-28%
78
N/A
285
+263%
(52)
N/A
62
N/A
Investing Cash Flow
Capital Expenditures
(205)
(133)
(137)
(165)
(188)
(217)
(255)
(349)
(300)
(296)
(327)
(314)
(312)
(318)
Other Items
(150)
(104)
(59)
(167)
(1 841)
(1 536)
(1 193)
(1 464)
(109)
7
(217)
405
540
36
Cash from Investing Activities
(355)
N/A
(236)
+33%
(196)
+17%
(332)
-69%
(2 030)
-511%
(1 752)
+14%
(1 448)
+17%
(1 813)
-25%
(409)
+77%
(289)
+29%
(544)
-88%
91
N/A
228
+150%
(282)
N/A
Financing Cash Flow
Net Issuance of Common Stock
6
0
6
1 756
1 760
0
0
(49)
(65)
(76)
116
174
181
192
Net Issuance of Debt
633
639
455
122
643
550
511
886
607
847
688
293
765
762
Cash Paid for Dividends
0
0
0
0
0
0
(5)
(7)
(18)
(19)
(23)
(48)
(60)
(59)
Other
(88)
(151)
(267)
(382)
(568)
(516)
(351)
(300)
(117)
(256)
(265)
(356)
(775)
(672)
Cash from Financing Activities
551
N/A
494
-10%
196
-60%
1 496
+664%
1 835
+23%
1 793
-2%
1 914
+7%
530
-72%
407
-23%
495
+22%
515
+4%
62
-88%
111
+79%
223
+100%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
Net Change in Cash
293
N/A
374
+27%
(79)
N/A
1 103
N/A
(204)
N/A
(144)
+30%
142
N/A
(1 661)
N/A
(274)
+84%
(140)
+49%
50
N/A
438
+779%
287
-34%
3
-99%
Free Cash Flow
Free Cash Flow
(107)
N/A
(17)
+84%
(216)
-1 179%
(226)
-5%
(198)
+12%
(401)
-103%
(579)
-44%
(727)
-25%
(572)
+21%
(642)
-12%
(249)
+61%
(29)
+88%
(363)
-1 146%
(256)
+29%

See Also

Summary
ONCO3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
ONCO3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ONCO3 stock valuation using valuation multiples.
Wall Street Estimates
ONCO3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ONCO3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 142,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.